Jia Jie Biomedical Co., Ltd.

Total Valuation

Jia Jie Biomedical Co., Ltd. carries a market capitalization of 1.43B, placing it among publicly traded companies globally. Its enterprise value stands at 1.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Jia Jie Biomedical Co., Ltd. currently has 118.74M shares outstanding.

Valuation Ratios

Jia Jie Biomedical Co., Ltd. trades at a trailing price-to-earnings ratio of 35.05. The price-to-sales ratio is 3.63, and the price-to-book ratio stands at 1.26.

Enterprise Valuation

On an enterprise value basis, Jia Jie Biomedical Co., Ltd. trades at an EV/EBITDA multiple of 1,958.55 and an EV/FCF ratio of 12.73. The EV/Sales ratio of 2.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,958.55 provides insight into valuation relative to core operating earnings.

Financial Position

Jia Jie Biomedical Co., Ltd. maintains a current ratio of 3.36, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.09, indicating elevated leverage, while an interest coverage ratio of 2.51 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Jia Jie Biomedical Co., Ltd. posts a return on equity of 3.79 and a return on invested capital of 0.04.

Taxes

Over the trailing twelve months, Jia Jie Biomedical Co., Ltd. has paid 7.75M in income taxes, reflecting an effective tax rate of 12.94.

Stock Price Statistics

Jia Jie Biomedical Co., Ltd.'s stock has declined approximately -21.75325% over the past 52 weeks. The 50-day moving average sits at 11.69, while the 200-day moving average is 13.88.

Income Statement

Over the trailing twelve months, Jia Jie Biomedical Co., Ltd. generated 485.40M in revenue and converted that into 50.26M in net income, yielding earnings per share of 0.46. EBITDA reached 696,000.00, while operating income came in at 696,000.00.

Balance Sheet

Jia Jie Biomedical Co., Ltd. holds 481.56M in cash and equivalents against 52.96M in total debt, resulting in a net debt position of -246.17M. Total book value stands at 1.40B, with working capital of 403.64M providing operational flexibility.

Cash Flow

Jia Jie Biomedical Co., Ltd. produced 21.34M in operating cash flow over the past twelve months. After subtracting -85.50M in capital expenditures, free cash flow totaled -64.15M - equivalent to -0.56 per share.

Margins

Jia Jie Biomedical Co., Ltd. operates with a gross margin of 30.97, reflecting its pricing power and cost economics. The operating margin of 0.14 and net profit margin of 10.35 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Jia Jie Biomedical Co., Ltd.'s most recent stock split took place on March 21, 2019 with a 10000000:8487829 split ratio.

Scores

Jia Jie Biomedical Co., Ltd. posts an Altman Z-Score of 6.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.